FSD BioSciences, Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, a proprietary ultra-micronized PEA formulation, for the treatment of inflammatory diseases ...View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005456/en/ ... SOURCE.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 31, 2023--. Sarepta Therapeutics, Inc ... The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4) ... About Sarepta Therapeutics ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005448/en/ ... FDAHEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY. SOURCE.
The "High Potency Active Pharmaceutical Ingredients Market, by Product, by Manufacturer, by Drug, by Application, and by Region - GlobalForecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering ...High Potency Active Pharmaceutical Ingredients Market Report 2022 - 2033 ... High Potency Active Pharmaceutical Ingredients ... SOURCE.
AUSTIN, Texas--(BUSINESS WIRE)--Mar 31, 2023--. Savara Inc. (Nasdaq... About Savara ... www.linkedin.com/company/savara-pharmaceuticals/ ). View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005098/en/ ... BIOTECHNOLOGY PHARMACEUTICAL FINANCE GENERAL HEALTH HEALTH PROFESSIONAL SERVICES CLINICAL TRIALS OTHER HEALTH. SOURCE ... PUB.
PITTSBURGH, March 31, 2023 /PRNewswire/ -- Lipella PharmaceuticalsInc ...JonathanKaufman, Co-founder and CEO of Lipella Pharmaceuticals, commented, "Last year we focused on developing our corporate profile and scientific mission to address serious diseases with significant unmet need ... Lipella Pharmaceuticals Inc ... SOURCE Lipella Pharmaceuticals Inc.
CANbridge Pharmaceuticals, Inc ... About CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals Inc ... For more on CANbridge Pharmaceuticals Inc., please go to ...View source version on businesswire.com.https.//www.businesswire.com/news/home/20230330005789/en/ ... CANbridge Pharmaceuticals Inc ... HEALTH GENERAL HEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY.
DALLAS--(BUSINESS WIRE)--Mar 31, 2023--. AISHealthcare is proud to recognize March as Multiple Sclerosis Awareness (MS) month ... About AIS Healthcare ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005433/en/. CONTACT ... MEDICAL SUPPLIES MEDICAL DEVICES HEALTH OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL. SOURCE ... PUB ... .
ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 31, 2023-- ... Genomic Medicines and Rare DiseaseDays, taking place from Monday, April 3 to Tuesday, April 4, 2023 in New York, NY ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005122/en/. CONTACT ... KEYWORD ... BIOTECHNOLOGY HEALTHGENETICS PHARMACEUTICAL CLINICAL TRIALS. SOURCE.
DALLAS--(BUSINESS WIRE)--Mar 31, 2023-- ... About AISHealthcare. Advancing quality. Improving lives ... Learn more at aiscaregroup.com. View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005432/en/. CONTACT. SimonCastellanos ... OTHER CONSUMER HEALTH CONSUMER GENERAL HEALTH PHARMACEUTICAL PEOPLE WITH DISABILITIES. SOURCE ... PUB ... .
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Mar 31, 2023-- ... apotherapy and biovectorisation. Cyrille TUPIN, Chief Executive Officer of ABIONYX Pharma, said ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005400/en/ ... HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL OPTICAL BIOTECHNOLOGY. SOURCE.
“A total of around €10m is suspected to have gone through accounts linked to her, including almost €7m in her ‘business’ account.”Detectives have said the suspect has no significant trappings of wealth.Virtually all the cash that went ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Mar 30, 2023-- ... The award is named in honor of Robert L. Wears, M.D., MS, PhD, for his pioneering work to improve patient safety. Dr ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230330005823/en/ ... HEALTH HOSPITALS CLINICAL TRIALS GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY. SOURCE.
SAN DIEGO--(BUSINESS WIRE)--Mar 31, 2023-- ... The three-year URAC accreditation for PBM covers 10 quality modules ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005080/en/ ... TECHNOLOGY MEDICAL SUPPLIES HOSPITALS TELEMEDICINE/VIRTUAL MEDICINE SOFTWARE BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH. SOURCE ... PUB.
SAN DIEGO--(BUSINESS WIRE)--Mar 31, 2023--. AriBio Co., Ltd ... The trial enrolled 210 patients at 21 research centers in the United States... Enrollment is expected to continue through 2024 ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005009/en/ ... BIOTECHNOLOGY NEUROLOGY MENTAL HEALTH HEALTH PHARMACEUTICAL. SOURCE.
LONDON, Ontario--(BUSINESS WIRE)--Mar 31, 2023-- ... CONFERENCE CALL - Tuesday, April 18, 2023 at 8.30 a.m. (EDT). ... (EDT) ... The conference ID is 00296074 ... General ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005096/en/ ... ALTERNATIVE MEDICINE CANNABIS RETAIL HEALTHNATURAL RESOURCES PHARMACEUTICAL FOOD/BEVERAGE. SOURCE.